M&A
-
Haemonetics to offload whole-blood business for up to $67M
Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.
By Susan Kelly • Dec. 4, 2024 -
GE Healthcare to buy radiopharmaceutical firm Nihon Medi-Physics
GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.
By Elise Reuter • Dec. 3, 2024 -
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.
By Elise Reuter • Nov. 25, 2024 -
Medtronic buys surgical instrument developer Fortimedix
Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.
By Nick Paul Taylor • Nov. 22, 2024 -
Henry Schein to acquire medical supplier Acentus
Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.
By Ricky Zipp • Nov. 21, 2024 -
Boston Scientific closes $3.7B Axonics deal after lengthy review
Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission requested more information.
By Ricky Zipp • Nov. 15, 2024 -
Tempus AI to buy genetic testing company for $600M
CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing business.
By Elise Reuter • Nov. 6, 2024 -
Boston Scientific continues M&A run with Cortex buy
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.
By Ricky Zipp • Nov. 4, 2024 -
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people
Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in Minnesota.
By Elise Reuter • Oct. 28, 2024 -
The Medtech Conference
That’s a wrap: 5 takeaways from The Medtech Conference
The conference — Advamed’s largest — featured an appearance by the device center’s new acting director and sessions on AI, clinical trial diversity and the FDA’s contentious LDT rule.
By Elise Reuter • Oct. 22, 2024 -
Hologic to buy Gynesonics for $350M to acquire fibroid system
Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for an incision.
By Nick Paul Taylor • Oct. 15, 2024 -
Sponsored by Nemphos Braue
5 reasons why MedTech M&A is poised for growth
In spite of uncertainties, the outlook for MedTech M&A is strong. Hint: AI isn’t the (only) factor.
By Caroline Popper, Nemphos Braue LLC • Oct. 7, 2024 -
Integer sells non-medical business for $50M
After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will use proceeds from the sale to pay down debt.
By Susan Kelly • Oct. 2, 2024 -
What’s next at Masimo after CEO Kiani’s exit?
Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.
By Susan Kelly • Sept. 30, 2024 -
Stryker adds devices to remove brain tumors, clots with Nico buy
Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
By Nick Paul Taylor • Sept. 23, 2024 -
Masimo proxy fight nears end as shareholder vote looms
Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.
By Susan Kelly • Sept. 19, 2024 -
Merit Medical inks $210M takeover of Cook’s lead management business
Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.
By Nick Paul Taylor • Sept. 18, 2024 -
Bausch + Lomb considers sale: FT
Private equity could be “the most likely” buyer of the eye care business, analysts wrote.
By Elise Reuter • Sept. 16, 2024 -
Boston Scientific closes Silk Road Medical acquisition
Completion of the purchase comes three months after the companies announced the deal, and after Boston Scientific resubmitted its merger filing to give the FTC more review time.
By Ricky Zipp • Updated Sept. 17, 2024 -
Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook
Acquisitions of late-stage VC startups have been rare, a fact Pitchbook attributed to “ongoing price gaps between buyers and sellers.”
By Nick Paul Taylor • Sept. 4, 2024 -
Illumina avoids fine for Grail purchase in European court victory
Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
By Susan Kelly • Sept. 3, 2024 -
UFP to buy device component maker AQF Medical, extending deal spree
AQF makes foam and thermoplastic components for use in medical devices and packaging.
By Nick Paul Taylor • Aug. 28, 2024 -
Siemens Healthineers to grow PET imaging with purchase of Novartis assets
Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.
By Nick Paul Taylor • Aug. 27, 2024 -
Getinge to buy Paragonix organ-preserving tech for up to $477M
Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.
By Ricky Zipp • Aug. 23, 2024 -
Quest inks deal for University Hospitals’ outreach lab services
The deal continues Quest’s expansion in Ohio and extends a string of acquisitions that began in May.
By Nick Paul Taylor • Aug. 23, 2024